Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To demonstrate that QVA149 (110/50 μg o.d.) is superior to NVA237 (50 μg o.d.) with regard to the rate of moderate to severe COPD exacerbations during 52 weeks of treatment.
Critère d'inclusion
- Chronic Obstructive Pulmonary Disease (COPD)